Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

AbbVie Inc. (ABBV) Our Analysis

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ABBVAbbVie Inc.Follow ABBV — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
504.8B
P/E TTM
80.7
Dividend yield
2.4%
52-week
—
Next earnings
30 Oct, in 6 days

Every figure on this page comes from AbbVie Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.